K2 HealthVentures Restructures Debt for Molecular Templates
Molecular Templates, a clinical-stage biopharmaceutical company, entered into a restructuring agreement with K2 HealthVentures to satisfy and discharge its outstanding secured debt obligations.
June 20, 2023
K2 HealthVentures | Molecular Templates | Stifel Nicolaus & Company
Markiesha Thompson